(Total Views: 268)
Posted On: 08/24/2022 8:45:58 AM
Post# of 88

$SLS News Article - SELLAS Life Sciences' Highly Selective CDK9 Inhibitor, GFH009, Demonstrates Cancer Cell Growth Inhibition in Preclinical In Vitro Model of Neuroendocrine Prostate Cancer Cell Line https://marketwirenews.com/news-releases/sell...40795.html


My Twitter: WhyteStocks